LOS ANGELES, CA / ACCESSWIRE / January 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of agilon health, inc. ("agilon" or "the Company") (NYSE:AGL) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Agilon reduced its guidance for fiscal year 2024 on January 5, 2024. The Company also announced its Chief Financial Officer would step down in 2024. Citron Research commented on the Company's announcement, stating that its "radar was spot-on in 2022, catching onto the clear signs of management manipulation. Insider selling of 87 million shares in a secondary offering at $21.5 just 8 months ago raises serious questions." Based on this news, shares of agilon dropped by 29.55% in intraday trading.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].
The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.
310-301-3335
[email protected]
www.schallfirm.com
SOURCE: The Schall Law Firm